A detailed history of Squarepoint Ops LLC transactions in Genmab A/S stock. As of the latest transaction made, Squarepoint Ops LLC holds 8,802 shares of GMAB stock, worth $180,176. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,802
Holding current value
$180,176
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.84 - $28.48 $209,839 - $250,680
8,802 New
8,802 $214,000
Q1 2024

May 15, 2024

BUY
$26.43 - $32.77 $35,759 - $44,337
1,353 Added 7.62%
19,116 $571,000
Q4 2023

Feb 14, 2024

SELL
$27.94 - $35.44 $61,915 - $78,535
-2,216 Reduced 11.09%
17,763 $565,000
Q2 2023

Aug 14, 2023

BUY
$37.4 - $42.94 $46,189 - $53,030
1,235 Added 6.59%
19,979 $759,000
Q1 2023

May 15, 2023

SELL
$34.88 - $43.22 $51,168 - $63,403
-1,467 Reduced 7.26%
18,744 $707,000
Q4 2022

Feb 14, 2023

SELL
$33.8 - $47.06 $911,890 - $1.27 Million
-26,979 Reduced 57.17%
20,211 $856,000
Q3 2022

Nov 14, 2022

BUY
$31.52 - $373.61 $1.49 Million - $17.6 Million
47,190 New
47,190 $1.52 Million
Q1 2021

May 17, 2021

SELL
$30.92 - $44.4 $285,422 - $409,856
-9,231 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$33.66 - $40.76 $310,715 - $376,255
9,231 New
9,231 $375,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.